Researchers have found that people with 2 copies of the APOE4 gene is more than a risk factor – it is now considered an underlying cause of Alzheimer’s Disease. Prior to the research’s finding published in May, scientists knew the gene APOE4 increased risk. Although...
Earlier this year, leqembi (a drug that slows memory decline for those in the early stages of Alzheimer’s Disease by targeting the amyloid protein, usually common with those inflicted with Alzheimer’s as it begins to form) was approved by both FDA and CMS (governmental assistance...
A milestone event in the fight against Alzheimer’s Disease occurred on July 6 when the FDA gave approval for a drug (Leqembi) that not only slows memory loss for those with Alzheimer’s Disease, but it was granted funding approval by the Centers for Medicare &...
Recent research and studies have shown a genetic link between Alzheimer’s Disease and gastrointestinal tract disorders. Although this doesn’t necessarily mean that gut disorders cause Alzheimer’s Disease, it does indicate that people with gut disorders may be at greater risk of developing Alzheimer’s Disease. As...
The FDA has recently approved the medication Aducanumab (which is to be given by infusion every four weeks) that studies have shown to slow the decline of cognitive and functional ability of patients (particularly if in the early stages after a diagnosis or those with...
It was recently announced that a simple blood test could be effective in diagnosing Alzheimer’s Disease (even if the person seemed normal) 20 years before memory and thinking problems are to be expected in people with a genetic mutation that causes Alzheimer’s. Although the blood test...
The House of Representatives, with bipartisan support, passed two bills on October 28 that are important to those impacted by Alzheimer’s disease. The Palliative Care and Hospice Education and Training Act (PCHETA) increases the availability and quality of care by creating hospice workforce and palliative...
The Senate Labor-HHS Appropriations Subcommittee has proposed a $350 million increase, raising the total to $2.8 billion annually if passed into law, for research funding on Alzheimer’s and dementia for year 2020. The Senate Subcommittee saw the progress in dementia research being made by researchers...
In an effort to make it easier for those suffering dementia to live independently instead of going to a nursing home, the Queen of Sweden (Queen Silvia), furniture maker Ikea, along with Skanska (a Swedish construction company) are teaming up to provide comfortable living solutions....
The U.S. National Institute of Aging (NIA) is giving the University of California, Berkley a five year grant expected to total $47 million to determine whether lifestyle changes will reduce the risk of developing Alzheimer’s disease. The study will be used to determine if lifestyle interventions...
